References
- AMATO, G., LONGO, V., MAZZACCARO, A. and GERVASI, P. G., 1996, Microsomal oxidation of N,N-diethylformamide and its effects on P450-dependent monoxygenases in rat liver. Chemical Research in Toxicology, 9, 882–890.
- BURKE, M. D. and MAYER, R. T., 1983, Differential effects of phenobarbitone and 3-methylcholanthrene induction on the hepatic microsomal metabolism and cytochrome P450-binding of phenoxazone and a homologous series of its O-alkylethers (alkoxyresorufin). Chemico-Biological Interactions, 45, 243–258.
- EKINS, S., VANDERBRANDEN, M., RING, B. J. and WRIGHTON, S. A., 1997, Examination of purported probes of human CYP2B6. Pharmacogenetics, 7, 165–179.
- FUJITA, S., MORIMOTO, R., CHIBA, M., KITANI, K. and Suzuxi, T., 1989, Evaluation of the involvement of male specific P450 isozyme in a senescence-associated decline of hepatic drug metabolism in male rats. Biochemical Pharmacology, 38, 325–331.
- JO, J. W., DESTA, Z. and FLOCKHART, D. A., 1998, Human N-demethylation of (S)-mephenytoin by cytochrome P450s 2C9 and 2B6. Drug Metabolism and Disposition, 26, 775–778.
- KAMINSKY, L. S., FRASER, J. M., SEAMAN, M. and DUNBAR, D., 1992, Rat liver metabolism and toxicity of 2,2,2-trifluoroethanol. Biochemical Pharmacology, 44, 1829–1837.
- KOENIGS, L. L., PETER, R. M., THOMPSON, S. J., RETTIE, A. E. and TRAGER, W. F., 1997, Mechanism-based inactivation of human liver cytochrome P4502A6 by 8-methoxypsoralene. Drug Metabolism and Disposition, 25, 1407–1415.
- KUNITOH, S., IAMAOKA, S., HIROI, T., YABUSAKI, Y., MONNA, T. and FUNAE, Y., 1997, Acetaldehyde as well as ethanol is metabolized by human CYP2E1. Journal of Pharmacology and Experimental Therapeutics, 280, 527–532.
- LEWIS, D. F. V., 1998, The CYP2 family: models, mutants and interactions. Xenobiotica, 28, 617–661.
- LINDAHL, R. and PETERSON, D. R., 1991, Lipid aldehyde oxidation as a physiological role for class 3 aldehyde dehydrogenases. Biochemical Pharmacology, 41, 1583–1587.
- LONGO, V., CITTI, L. and GERVASI, P. G., 1986, Metabolism of diethylnitrosamine by nasal mucosa and hepatic microsomes from hamster and rat: species specificity of nasal mucosa. Carcinogenesis, 7, 1323–1328.
- LOWRY, D. H., ROSEBROUGH, N. J., FARR, A. L. and RANDALL, R. J., 1951, Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193, 265–275.
- MAYER, R. T., NETTER, K. J., HENBEL, F., HAHNEMANN, B., BUCHHEISTER, A., MAYER, G. K. and BURKE, M. D., 1990, 7-Alkoxyquinolines: new fluorescent substrates for cytochrome P450 monoxygenases. Biochemical Pharmacology, 40, 1645–1655.
- PARKINSON, A., 1996, Biotrasformation of xenobiotics. In C. D. Klaassen (ed.), Toxicology: The Basic Science of Poisons (New York: McGraw-Hill), pp. 113–186.
- RYAN, D. E. and LEVIN, W., 1990, Purification and characterization of hepatic microsomal cytochrome P450. Pharmacology and Therapeutics, 45, 153–239.
- SAI, Y., DAI, R., YANG, T. J., KRAUSZ, K. W., GONZALES, F. J., GELBOIN, H. V. and SHOU, M., 2000, Assessment of specificity of eight chemical inhibitors using cDNA-expressed cytochromes P450. Xenobiotica, 30, 327–343.
- SHIMADA, T., YAMAZAKI, H., MIMURA, M., INUI, Y. and GUENGERICH, F. P., 1994, Interindividual variations in human liver cytochrome P450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. Journal of Pharmacology and Experimental Therapeutics, 270, 414–423.
- SMITH, D. A., 1991, Species differences in metabolism and pharmacokinetics: are we close to an understanding? Drug Metabolism Reviews, 23, 355–373.
- SOUCEK, P. and GUT, I., 1992, Cytochromes P450 in rats: structures, functions, properties and relevant human forms. Xenobiotica, 22, 83–103.
- WATANABE, K., MATSUNAGA, T., NARIMATSU, S., YAMAMOTO, I. and YASHIMURA, H., 1992, Mouse hepatic microsomal oxidation of aliphatic aldehydes (C8 to C11) to carboxylic acids. Biochemical and Biophysical Research Communications, 188, 114–119.
- WATANABE, K., MATSUNAGA, T., YAMAMOTO, I. and YOSHIMURA, H., 1995, Oxidation of tolualdehydes to toluic acids catalyzed by cytochrome P450 dependent aldehyde oxygenase in the mouse liver. Drug Metabolism and Disposition, 23, 261–265.
- WATANABE, K., NARIMATSU, S., MATSUNAGA, T., YAMAMOTO, I. and YASHIMURA, H., 1993, A cytochrome P450 isozyme having aldehyde oxygenase activity plays a major role in metabolizing cannabionoids by mouse hepatic microsomes. Biochemical Pharmacology, 46, 405–411.
- WATANABE, K., NARIMATSU, S., YAMAMOTO, I. and YOSHIMURA, H., 1990, Hepatic microsomal oxygenation of aldehydes to carboxylic acids. Biochemical and Biophysical Research Communications, 166, 1308–1312.
- WATANABE, K., OZAKI, M., MATSUNAGA, T., YAMAMOTO, I. and YOSHIMURA, H., 1991, Fluorimetric assay of microsomal aldehyde oxygenase activity: 9-anthraldehyde as a substrate. Analytical Biochemistry, 198, 134–137.
- WRIGHTON, S. A., VANDERBRANDEN, M., STEVENS, J. C., SHIPLEY, L. A., RING, B. J., RETTIE, A. E. and CASHMAN, J. R., 1993, In vitro methods for assessing human hepatic drug metabolism: their use in drug development. Drug Metabolism Reviews, 25, 453–484.
- ZHANG, Q., DUNBAR, D. and KAMINSKY, L., 2000, Human cytochrome P450 metabolism of retinals to retinoic acids Drug Metabolism and Disposition, 28, 292–297.